Live | Norge | Sverige | Danmark | Europa | USA | Valuta | Råvarer | Gråmarked | Fond | NDXForsinkede kurser. Sist oppdatert: onsdag 13. desember
Teknisk analyse
Nyheter
Om PHO
Intradagsgraf
Korrelasjoner
Handelslogg
Dybdelogg
Dataeksport
Legg til interesseliste
Handle PHO
Sanntidssnapshot
Dato Antall dager Distributør Papir Børs Søk  
Dato Tid Selskap Overskrift
08/12-2017 08:54:00 PHO Photocure med resultater fra studie (Hegnar)
  08:20:04 PHO Photocure ASA: Landmark Blue Light Cystoscopy with Cysview® study is published in the Journal of Urology (GlobeNewswire)
05/12-2017 13:02:28 PHO Photocure ASA: Presentation at the Carnegie Nordic Healthcare Day, New York (GlobeNewswire)
01/12-2017 08:32:46 PHO Photocure ASA: Blue Light Flexible Cystoscopy with Cysview® Phase 3 study: New data presented at Society of Urological Oncology (GlobeNewswire)
27/11-2017 15:35:05 PHO Financial calendar (OBI)
09/11-2017 13:48:00 PHO Photocure presenterer lovende resultater (Hegnar)
  13:12:30 PHO Photocure ASA: Clinical and cost impact analysis shows beneficial impact of replacing current surgical modalities with Cevira (OBI)
  11:26:00 PHO NAS WWL Advarer mot to aksjer (Hegnar)
08/11-2017 14:57:00 PHO Millionsmell i Photocure (Hegnar)
  07:21:00 PHO Photocure øker tapene (Hegnar)
  07:15:30 PHO Photocure ASA: Results for the third quarter of 2017 (GlobeNewswire)
02/11-2017 09:09:00 PHO Photocure oppdaterer markedet (Hegnar)
  08:07:16 PHO Photocure ASA:U.S. CMS improves reimbursement for Blue Light Cystoscopy with Cysview® (GlobeNewswire)
31/10-2017 11:09:12 PHO Photocure ASA: Presentation of the third quarter 2017 results (GlobeNewswire)
23/10-2017 12:10:42 PHO Photocure ASA: BLC(TM) with Cysview®/Hexvix® real World Data presented at the Société Internationale d'Urologie 2017 Annual meeting (OBI)
18/10-2017 08:48:00 PHO Photocure har fått ja til gjennomgang av søknad (Hegnar)
  08:16:31 PHO Photocure ASA: FDA grants priority review for Cysview® supplemental New Drug Application (sNDA) (GlobeNewswire)
09/10-2017 15:10:00 PHO Hansson på ny handletur i Photocure (Hegnar)
02/10-2017 13:59:00 PHO Hansson laster opp i Photocure (Hegnar)
29/09-2017 17:05:00 PHO - Totalt uaktuelt å selge aksjene (Hegnar)
12/09-2017 13:24:42 PHO Financial calendar (OBI)
07/09-2017 13:02:00 PHO SOFF BWO Advarer mot flere aksjer (Hegnar)
23/08-2017 07:21:00 PHO Photocure tapte 5 millioner (Hegnar)
  07:12:04 PHO Photocure ASA: Results for second quarter and first half year of 2017 (GlobeNewswire)
21/08-2017 08:49:00 PHO Hunter Hall selger unna aksjer i Photocure (Hegnar)
  08:29:35 PHO Pengana/HunterHall- reduction in holding- Photocure ASA (OBI)
18/08-2017 08:57:39 PHO Photocure ASA: Blue Light Cystoscopy with Hexvix® reduces recurrence rate at 3 years in real-life experience study (OBI)
16/08-2017 14:45:50 PHO Photocure ASA: Presentation of the second quarter and first half year 2017 results (GlobeNewswire)
  14:25:53 PHO Photocure files supplemental New Drug Application with FDA for Blue Light Cystoscopy (BLC(TM)) with Cysview® (OBI)
31/07-2017 13:04:01 PHO Photocure ASA: First European study to show that Blue Light Flexible Cystoscopy with Hexvix® can replace conventional follow up of CIS patients (OBI)
26/07-2017 08:59:00 PHO Selger aksjer i Photocure (Hegnar)
  08:22:52 PHO Disclosure of shareholding (OBI)
17/07-2017 16:35:00 PHO TEL Ny rekorddag på Oslo Børs (Hegnar)
  12:21:00 TEL PHO Aksje til topps etter ny milepæl (Hegnar)
  11:47:00 PHO Photocure opplyser om refusjonsutvidelse (Hegnar)
  08:03:56 PHO Photocure ASA : UPDATE ON MEDICARE REIMBURSEMENT FOR BLUE LIGHT CYSTOSCOPY WITH CYSVIEW® (OBI)
30/05-2017 14:13:35 PHO Flaggemelding Photocure ASA (OBI)
23/05-2017 07:17:00 PHO Fortsatt røde tall for Photocure (Hegnar)
  07:04:33 PHO Photocure ASA: Results for the first quarter of 2017 (GlobeNewswire)
16/05-2017 14:53:28 PHO Photocure ASA: Presentation of the first quarter 2017 results and the results from the Blue Light Flexible Cystoscopy with Hexvix®/Cysview® phase 3 study (GlobeNewswire)
15/05-2017 12:12:00 PHO STL APCL Flere aksjer faller etter nyheter (Hegnar)
  09:20:00 PHO Photocure oppdaterer markedet (Hegnar)
  08:30:00 PHO Positive data from Phase 3 US Blue Light Cystoscopy with Cysview® study presented at AUA 2017 meeting in Boston (OBI)
12/05-2017 09:10:00 PHO Photocure oppdaterer markedet (Hegnar)
  08:29:05 PHO Photocure ASA: Phase 3 study investigating Blue Light Flexible Cystoscopy with Cysview® in surveillance setting meets primary endpoint (GlobeNewswire)
05/05-2017 08:47:00 PHO Ny direktør i Photocure (Hegnar)
  08:00:00 PHO Jeremy Bahr appointed Chief Business Officer (OBI)
28/04-2017 08:53:00 PHO Endringer i Photocure-styret (Hegnar)
  08:00:02 PHO Photocure Appoints Three New Members to its Board of Directors (OBI)
27/04-2017 20:53:28 PHO Photocure ASA: Annual general meeting held (GlobeNewswire)
Sidestørrelse:
Utforming |  Hjelp |  Utskrift  | Bytt til sanntid Ingen åpne markeder
onsdag 13/12-2017 06:20:55